Search Results - "Hartana, Ciputra"
-
1
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway
Published in PloS one (2018)“…The immune system plays a significant role in urothelial bladder cancer (UBC) progression, with CD8+ T cells being capable to directly kill tumor cells using…”
Get full text
Journal Article -
2
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness
Published in Cancer immunology research (01-05-2018)“…Regulatory T cells (Treg) have long been considered one-sided suppressors of antitumor immune responses and hence associated with poor patient outcome in…”
Get more information
Journal Article -
3
IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers
Published in Cell reports (Cambridge) (26-12-2023)“…As the principal effector cell population of the innate immune system, natural killer (NK) cells may make critical contributions to natural, immune-mediated…”
Get full text
Journal Article -
4
Increased CD4 + T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
Published in Clinical epigenetics (03-08-2018)“…Urinary bladder cancer is a common malignancy worldwide. Environmental factors and chronic inflammation are correlated with the disease risk. Diagnosis is…”
Get full text
Journal Article -
5
Immunological effector mechanisms in HIV-1 elite controllers
Published in Current opinion in HIV & AIDS (01-09-2021)“…HIV-1 elite controllers encompass small populations of people infected with HIV-1 who can spontaneously control plasma viral loads below the limit of…”
Get full text
Journal Article -
6
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Published in Cell (01-10-2020)“…Humoral responses in coronavirus disease 2019 (COVID-19) are often of limited durability, as seen with other human coronavirus epidemics. To address the…”
Get full text
Journal Article -
7
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Published in Science (American Association for the Advancement of Science) (27-11-2020)“…Understanding humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for improving diagnostics, therapeutics, and…”
Get full text
Journal Article -
8
Immunological effector mechanisms in HIV-1 elite controllers
Published in Current opinion in HIV & AIDS (15-07-2021)Get full text
Journal Article -
9
Phenotypic signatures of immune selection in HIV-1 reservoir cells
Published in Nature (London) (09-02-2023)“…Human immunodeficiency virus 1 (HIV-1) reservoir cells persist lifelong despite antiretroviral treatment 1 , 2 but may be vulnerable to host immune responses…”
Get full text
Journal Article -
10
Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers
Published in The Journal of clinical investigation (03-05-2021)“…Restriction of HIV-1 replication in elite controllers (ECs) is frequently attributed to T cell-mediated immune responses, while the specific contribution of…”
Get full text
Journal Article -
11
Long noncoding RNA MIR4435-2HC enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers
Published in The Journal of clinical investigation (01-05-2021)“…Restriction of HIV-1 replication in elite controllers (ECs) is frequently attributed to T cell-mediated immune responses, while the specific contribution of…”
Get full text
Journal Article -
12
Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates
Published in The Journal of infectious diseases (11-08-2023)“…Abstract Immune mechanisms that modulate human immunodeficiency virus-1 (HIV-1) reservoir size in neonates are poorly understood. Using samples from neonates…”
Get full text
Journal Article -
13
Immune correlates of HIV-1 reservoir cell decline in early-treated infants
Published in Cell reports (Cambridge) (19-07-2022)“…Initiation of antiretroviral therapy (ART) in infected neonates within hours after birth limits viral reservoir seeding but does not prevent long-term HIV-1…”
Get full text
Journal Article -
14
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer
Published in European urology (01-12-2018)“…Evidence indicates that neoadjuvant chemotherapy (NAC) may promote antitumour immune responses by activating T cells. The tumour-draining sentinel node (SN) is…”
Get full text
Journal Article -
15
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
Published in Expert opinion on biological therapy (03-08-2019)“…In recent years, immunotherapy for the treatment of solid cancer has emerged as a promising therapeutic alternative. Adoptive cell therapy (ACT), especially T…”
Get more information
Journal Article -
16
Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours
Published in British journal of cancer (11-10-2016)“…Background: Stage is an important prognostic factor in renal tumours and dissemination to regional lymph nodes is associated with poor outcomes. Lymph nodes…”
Get full text
Journal Article -
17
Urothelial bladder cancer may suppress perforin expression in CD8.sup.+ T cells by an ICAM-1/TGF[beta]2 mediated pathway
Published in PloS one (02-07-2018)“…The immune system plays a significant role in urothelial bladder cancer (UBC) progression, with CD8.sup.+ T cells being capable to directly kill tumor cells…”
Get full text
Journal Article -
18
SARS-CoV-2 epitope-specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability
Published in Science immunology (22-07-2022)“…CD4 T cells are central to long-term immunity against viruses through the functions of T helper 1 (T 1) and T follicular helper (T ) cell subsets. To better…”
Get more information
Journal Article -
19
Doxorubicin enhances the capacity of B cells to activate T cells in Urothelial Urinary Bladder Cancer
Published in Clinical immunology (Orlando, Fla.) (01-03-2017)“…Abstract Cancer is currently treated by a combination of therapies, including chemotherapy which is believed to suppress the immune system. Combination of…”
Get full text
Journal Article -
20
T Cells in Solid Tumors : Investigating the Immunomodulation in the Tumor Microenvironment
Published 01-01-2018“…The immune system protects human from cancer through an immuno surveillance mechanism. However, the progressive nature of tumor cells to differentiate and the…”
Get full text
Dissertation